EyePoint Pharmaceuticals (EYPT) Earnings Analysis
EyePoint Pharmaceuticals (EYPT) has no confirmed upcoming earnings date. Last quarter (2026-03-04) it missed with EPS -0.81 USD vs -0.78 USD est (-3.8%). It has beaten estimates in 0/3 recent quarters (0%). Trailing P/E -3.62.
Last updated 2026-07-23 · Source: FMP fundamentals + earnings calendar (company filings); consensus from sell-side analyst grades
When does EYPT next report earnings?
No confirmed upcoming earnings date is currently scheduled for EYPT. This page updates as the calendar is published.
EYPT earnings history — beats and misses
| Quarter (report date) | EPS actual | EPS est. | Surprise | Result |
|---|---|---|---|---|
| 2026-03-04 | -0.81 USD | -0.78 USD | -3.8% | Miss |
| 2025-03-05 | -0.64 USD | -0.54 USD | -18.5% | Miss |
| 2024-11-07 | -0.54 USD | -0.48 USD | -12.5% | Miss |
Beat rate: 0/3 (0%) over reported quarters with consensus data.
EYPT valuation and analyst view
| Trailing P/E | -3.62 |
|---|---|
| Trailing EPS | -3.15816 USD |
| Price / book | 4.72 |
| Dividend yield | 0.00% |
| Market cap | 1.05B |
| Analyst consensus | Buy (16 buy / 2 hold / 0 sell) |
| Avg price target | 40 USD |
Related research pages
Frequently asked questions
When is EyePoint Pharmaceuticals (EYPT)'s next earnings date?
No confirmed upcoming earnings date is currently scheduled for EYPT. This page updates as the calendar is published.
Did EYPT beat earnings last quarter?
In its 2026-03-04 report, EYPT posted EPS of -0.81 USD versus a -0.78 USD estimate — a miss of 3.8%.
What is EYPT's earnings track record?
Over the last 3 reported quarters with consensus data, EYPT beat estimates 0 times (0%).
What is EYPT's current P/E ratio and EPS?
EYPT trades at a trailing P/E of -3.62 on trailing EPS of -3.158164629821277 USD.
What do analysts rate EYPT?
Analyst consensus is "Buy" across 18 ratings (0 strong buy, 16 buy, 2 hold, 0 sell, 0 strong sell). Average 12-month price target: 40 USD.